Jersey City, NJ, July 10, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on “Global Aseptic Fill Finish Market Size, Share & Trends Analysis Report By Molecules (Small Molecules & Biologics), Type of Packaging Containers (Ampoules, Cartridges, Syringes, and Vials), Drug Product Types (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines, and Other Products), Target Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases Oncological Disorders, and Other Disorders), Scale of Operation (Preclinical/Clinical and Commercial), Company Size (Large, Mid-sized, & Small) Market Outlook And Industry Analysis 2031."
According to the latest research by InsightAce Analytic, the Global Aseptic Fill Finish Market Size is expected to record a promising CAGR of 10.67% during the forecast period of 2023-2031.
Free PDF Report Brochure @ https://www.insightaceanalytic.com/request-sample/1880
Aseptic fill finish services include the precise and sterile filling/sealing of medicinal products into containers such as vials, syringes, ampoules and cartridges. These aseptic conditions during fill and finish operation are important to ensure the safety of the patients and maintain product quality. However, pharmaceutical manufacturers with limited funds and capacity may find it challenging to meet the needs of consumers due to the high cost of specialized equipment and qualified professionals for these jobs. Therefore, many stakeholders outsource their needs by contracting with service providers to ensure the development of quality products.
Currently, contract fill-finish services are one of the most commonly outsourced services. Increasing demand for drugs in the global market and the advantages of contract manufacturing in reducing the overall investment in pharmaceutical manufacturing are the main factors boosting business growth. Moreover, the COVID-19 pandemic stimulated the development of COVID-19 vaccines, antiviral drugs, and other related pharmaceutical products. Vaccines & biologics require special manufacturing and fill & finish systems and procedures to maintain product quality and safety. Thus, covid-19 outbreak positively impacted the aseptic fill finish market.
Key developments in the market:
- In May 2023, CordenPharma announced its entry into the synthetic Oligonucleotide manufacturing arena in CordenPharma Colorado. With an organic capex investment in Two Phases, the strategic expansion will provide innovative biotech and pharma customers with a fully-integrated API to Drug Product service offering organized under a new Oligonucleotides Platform.
- In January 2023, CordenPharma announced the signing of a multi-year agreement to manufacture a large-volume peptide at its CordenPharma Colorado facility, including aseptic fill and finish capabilities.
- In June 2022, Pierre Fabre and Lonza entered into a manufacturing agreement for W0180 Antibody Drug Product. Lonza will provide clinical drug product manufacturing for W0180, discovered by Pierre Fabre targeting solid tumours, from its fill and finish facility in Stein, Switzerland.
- In March 2021, GlaxoSmithKline offered fill and finish manufacturing capacity to Novavax for the supply of Covid-19 vaccine in the UK.
- In March 2021, Baxter BioPharma Solutions and Moderna collaborated to offer the fill/finish manufacturing services and supply packaging of the Moderna Covid-19 Vaccine in the U.S.
Some of the prominent players in the Aseptic Fill Finish Market are:
- AbbVie Contract Manufacturing
- Asymchem
- Aenova
- APL
- BioPharma Solutions
- BioReliance
- Boehringer Ingelheim BioXcellence
- Catalent Biologics
- Charles River Laboratories
- CordenPharma
- Delpharm
- Fareva
- Fresenius Kabi
- Glaxo SmithKline
- Hetero Drugs
- Intas Pharmaceuticals
- Lonza
- Pierre Fabre
- Pfizer CentreOne
- Plastikon Healthcare
- Patheon
- PiSA Farmaceutica
- Recipharm
- Wacker Biotech
- Syngene
- Sharp Services
- Siegfried
- Takara Bio
- WuXi Biologics
- Wockhardt
- Other Prominent Players
Aseptic Fill Finish Market Report Scope:
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of 10.67 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type of Molecules, By Type of Packaging Containers, By Type of Drug Products, By Target Therapeutic Area, By Scale of Operation, By Company Size |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Aenova, AbbVie Contract Manufacturing, APL, Asymchem, BioPharma Solutions, BioReliance, Boehringer Ingelheim BioXcellence, Catalent Biologics, Charles River Laboratories, CordenPharma, Delpharm, Fareva, Fresenius Kabi, Glaxo SmithKline, Hetero Drugs, Intas Pharmaceuticals, Lonza, Pierre Fabre, Patheon, Pfizer CentreOne, Plastikon Healthcare, PiSA Farmaceutica, Recipharm, Sharp Services, Wacker Biotech, Syngene, Takara Bio, WuXi Biologics, Siegfried, Wockhardt, and others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Enquiry Before Buying @ https://www.insightaceanalytic.com/enquiry-before-buying/1880
Market Dynamics:
Drivers:
The factors contributing to driving the aseptic fill-finish market are the high demand for outsourcing aseptic fill-finish services, the growing pipeline of drug products, in-house capacity constraints, technological developments, and increased awareness related to the benefits of aseptic fill-finish services.
Many pharma, biopharma, and contract manufacturing organizations have adopted single-use fill-finish systems, specifically for biologics. For example, PreVAS (Syntegon Technology GmbH) is a pre-assembled and pre-sterilized disposable filling system for vials, syringes, cartridges, and ampoules. This is mainly because single-use eliminates the need for expensive and time-consuming sterilization processes.
Challenges:
Aseptic fill-finish operations carry more risk than non-sterile processes. They require trained personnel, careful planning, and specialized facilities and equipment to perform the procedure. Maintaining a contamination-free environment is crucial as it can cause financial losses and affect patients' lives. Sterilization of components required for aseptic fill-finishing processes is also an additional step.
Regional Trends:
North America’s aseptic fill finish market is projected to hold the second-highest revenue share after Asia Pacific. Factors contributing to this growth are rising demand for diagnostics, increasing pharma & biopharma companies, well-established industrial infrastructure, advancement in medical technologies, increasing collaborations and agreements, and improved developmental capabilities of the contract manufacturing companies in this region.
Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Molecules
- Small Molecules
- Biologics
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Packaging Containers
- Vials
- Syringes
- Ampoules
- Cartridges
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Drug Products
- Vaccines
- Recombinantn Proteins
- Antibodies
- Oligonucleotides
- Gene Therapies
- Cell Therapies
- Other Products
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Target Therapeutic Area
- Autoimmune Disorders
- Cardiovascular Disorder
- Infectious Disorders
- Oncological Disorders
- Other Disorders
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Scale of Operation
- Preclinical / Clinical
- Commercial
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Company Size
- Large
- Mid-sized
- Small
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America Aseptic Fill Finish Market Revenue (US$ Million) by Country, 2023 to 2031
- U.S.
- Canada
Europe Aseptic Fill Finish Market Revenue (US$ Million) by Country, 2023 to 2031
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific Aseptic Fill Finish Market Revenue (US$ Million) by Country, 2023 to 2031
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America Aseptic Fill Finish Market Revenue (US$ Million) by Country, 2023 to 2031
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa Aseptic Fill Finish Market Revenue (US$ Million) by Country, 2023 to 2031
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Obtain Report Customization Details @ https://www.insightaceanalytic.com/customisation/1880
About Us:
InsighAce Analytic is a specializing in market research and consulting services that helps in building business strategies. Our mission is to provide high quality insights with using data analytics techniques and visualization tools that drives the disruption and innovation in market research industry. Our expertise is in providing syndicated and custom market intelligence reports with in-depth analysis and key market insights in a timely and cost-effective manner.
Follow Us @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Subscribe Our Exclusive Newsletters @ https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/
